Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases

Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.

Saved in:
Bibliographic Details
Main Authors Elmore Steven W, Sullivan Gerard M, Kunzer Aaron R
Format Patent
LanguageEnglish
Published 15.11.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Bibliography:Application Number: US201514855176